Lantern Pharma Inc. Common Stock LTRN

$2.65 +0.76% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-14 View →
10-Q 10-Q 2026-08-14 View →
8-K 8-K 2026-08-03 View →
S-1 S-1 2026-06-12 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-15 View →
10-Q 10-Q 2026-05-15 View →
8-K 8-K 2026-05-14 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
424B5 424B5 2026-05-14 View →
8-K 8-K 2026-04-10 View →
424B5 424B5 2026-03-30 View →
10-K 10-K 2026-03-30 View →
8-K 8-K 2026-03-30 View →
8-K 8-K 2026-01-23 View →
4 4 2026-01-13 View →
4 4 2026-01-13 View →
4 4 2026-01-13 View →
4 4 2026-01-13 View →
4 4 2026-01-13 View →
4 4 2025-12-22 View →
4 Insider transaction 2025-12-22 View →
8-K 8-K 2025-11-13 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-09-23 View →
4 4 2025-08-20 View →
8-K 8-K 2025-08-13 View →
10-Q 10-Q 2025-08-13 View →
DEF 14A DEF 14A 2025-08-08 View →
8-K 8-K 2025-07-29 View →
8-K 8-K 2025-07-03 View →
424B5 424B5 2025-07-03 View →
4 OWNERSHIP DOCUMENT 2025-06-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.65
Market Cap
$33.88 million
52-Week Range
$1.11 – $5.74
Average Volume
118K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.